Long Noncoding RNA MALAT1-regulated MicroRNA 506 Modulates Ovarian Cancer Growth by Targeting IASPP

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2016 Dec 30

PMID 28031721

Citations 39

Authors

Ruilin Lei

Min Xue

Lan Zhang

Zhongqiu Lin

Affiliations

Soon will be listed here.

Abstract

MALAT1, an important cancer-associated long noncoding RNA (lncRNA), contributes to the development and progression of several cancers. Disordered expression of MALAT1 has been observed in several cancers, including cervical cancer, breast cancer, and ovarian cancer. However, the exact effects and molecular mechanisms of MALAT1 in ovarian cancer progression are still unknown. Here, we investigated the role of MALAT1 in human ovarian cancer cell lines and clinical tumor samples, in order to determine the function of this molecule. In our research, lncRNA-MALAT1 was specifically upregulated in ovarian cancer cell lines and promoted ovarian cancer-cell growth through targeting microRNA (miR)-506. Knockdown of MALAT1 inhibited the proliferation and DNA synthesis of human ovarian cancer cell in vitro. In addition, miR-506-dependent iASPP regulation was required in MALAT1-induced ovarian cancer-cell growth. These findings indicated that MALAT1 might suppress tumor growth via miR-506-dependent iASPP regulation. Taken together, our data indicated that MALAT1 might be an oncogenic lncRNA that promotes proliferation of ovarian cancer and could be regarded as a therapeutic target in human ovarian cancer.

Citing Articles

Mechanistic actions of long non-coding RNA MALAT1 within the ovary and at the feto-maternal interface.

Adu-Gyamfi E, Cheeran E, Salamah J, Lee B Mol Biol Rep. 2024; 51(1):301.

PMID: 38353828 DOI: 10.1007/s11033-024-09220-2.

LncRNA MALAT1 signaling pathway and clinical applications in overcome on cancers metastasis.

Mazarei M, Rabori V, Ghasemi N, Salehi M, Rayatpisheh N, Jahangiri N Clin Exp Med. 2023; 23(8):4457-4472.

PMID: 37695391 DOI: 10.1007/s10238-023-01179-x.

Transcription factor c-fos induces the development of premature ovarian insufficiency by regulating MALAT1/miR-22-3p/STAT1 network.

Qiu T, Zhou J, Ji B, Yuan L, Weng T, Liu H J Ovarian Res. 2023; 16(1):144.

PMID: 37480147 PMC: 10362627. DOI: 10.1186/s13048-023-01212-3.

Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine.

Kandettu A, Adiga D, Devi V, Suresh P, Chakrabarty S, Radhakrishnan R Genes Dis. 2022; 9(6):1443-1465.

PMID: 36157483 PMC: 9485269. DOI: 10.1016/j.gendis.2021.12.026.

Long Non-coding RNA UCA1a Promotes Proliferation via PKM2 in Cervical Cancer.

Yu M, Xue S, Chen X, Wu K, Ju L, Tang J Reprod Sci. 2022; 30(2):601-614.

PMID: 35927414 DOI: 10.1007/s43032-022-01042-6.

References

Dong Y, Liang G, Yuan B, Yang C, Gao R, Zhou X . MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol. 2014; 36(3):1477-86. DOI: 10.1007/s13277-014-2631-4. View

Fellenberg J, Sahr H, Kunz P, Zhao Z, Liu L, Tichy D . Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6. Cancer Lett. 2015; 371(1):134-41. DOI: 10.1016/j.canlet.2015.10.039. View

Yang G, Zhang P, Lv A, Liu Y, Wang G . MiR-205 functions as a tumor suppressor via targeting TGF-α in osteosarcoma. Exp Mol Pathol. 2015; 100(1):160-6. DOI: 10.1016/j.yexmp.2015.12.010. View

Zehavi L, Avraham R, Barzilai A, Bar-ILan D, Navon R, Sidi Y . Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Mol Cancer. 2012; 11:44. PMC: 3444916. DOI: 10.1186/1476-4598-11-44. View

Hirata H, Hinoda Y, Shahryari V, Deng G, Nakajima K, Tabatabai Z . Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Cancer Res. 2015; 75(7):1322-31. PMC: 5884967. DOI: 10.1158/0008-5472.CAN-14-2931. View

Ruan W, Wang P, Feng S, Xue Y, Li Y . Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells. Tumour Biol. 2015; 37(3):4065-73. DOI: 10.1007/s13277-015-4256-7. View

Shi X, Sun M, Liu H, Yao Y, Song Y . Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013; 339(2):159-66. DOI: 10.1016/j.canlet.2013.06.013. View

Zhou S, Wang J, Zhang Z . An emerging understanding of long noncoding RNAs in kidney cancer. J Cancer Res Clin Oncol. 2014; 140(12):1989-95. DOI: 10.1007/s00432-014-1699-y. View

Xiao H, Tang K, Liu P, Chen K, Hu J, Zeng J . LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma. Oncotarget. 2015; 6(35):38005-15. PMC: 4741980. DOI: 10.18632/oncotarget.5357. View

10.

Yang M, Hu Z, Xu C, Xie L, Wang X, Chen S . MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochim Biophys Acta. 2014; 1852(1):166-74. PMC: 4268411. DOI: 10.1016/j.bbadis.2014.11.013. View

11.

Duan Z, Choy E, Harmon D, Liu X, Susa M, Mankin H . MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther. 2011; 10(8):1337-45. PMC: 3711153. DOI: 10.1158/1535-7163.MCT-11-0096. View

12.

Djebali S, Davis C, Merkel A, Dobin A, Lassmann T, Mortazavi A . Landscape of transcription in human cells. Nature. 2012; 489(7414):101-8. PMC: 3684276. DOI: 10.1038/nature11233. View

13.

Cai X, Liu Y, Yang W, Xia Y, Yang C, Yang S . Long noncoding RNA MALAT1 as a potential therapeutic target in osteosarcoma. J Orthop Res. 2015; 34(6):932-41. DOI: 10.1002/jor.23105. View

14.

Wang B, Su Y, Yang Q, Lv D, Zhang W, Tang K . Overexpression of Long Non-Coding RNA HOTAIR Promotes Tumor Growth and Metastasis in Human Osteosarcoma. Mol Cells. 2015; 38(5):432-40. PMC: 4443285. DOI: 10.14348/molcells.2015.2327. View

15.

Li Y, Ahmad A, Sarkar F . ASPP and iASPP: Implication in cancer development and progression. Cell Mol Biol (Noisy-le-grand). 2015; 61(6):2-8. View

16.

Formosa A, Markert E, Lena A, Italiano D, Finazzi-Agro E, Levine A . MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene. 2013; 33(44):5173-82. DOI: 10.1038/onc.2013.451. View

17.

Martens-Uzunova E, Bottcher R, Croce C, Jenster G, Visakorpi T, Calin G . Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 2013; 65(6):1140-51. DOI: 10.1016/j.eururo.2013.12.003. View

18.

Wang X, Li M, Wang Z, Han S, Tang X, Ge Y . Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J Biol Chem. 2014; 290(7):3925-35. PMC: 4326802. DOI: 10.1074/jbc.M114.596866. View

19.

Jin Y, Peng D, Shen Y, Xu M, Liang Y, Xiao B . MicroRNA-376c inhibits cell proliferation and invasion in osteosarcoma by targeting to transforming growth factor-alpha. DNA Cell Biol. 2013; 32(6):302-9. DOI: 10.1089/dna.2013.1977. View

20.

Gutschner T, Hammerle M, Diederichs S . MALAT1 -- a paradigm for long noncoding RNA function in cancer. J Mol Med (Berl). 2013; 91(7):791-801. DOI: 10.1007/s00109-013-1028-y. View